Discover Great Companies Discover Great Clients
Popularity  3.3万   |   Followers  13   |   Likes  24   |   Feedback  8 Claim this company

Provider of regenerative medicine products, technologies, and services

No.242 Huangpu District Popularity Ranking Guangzhou City Guangdong No.1 Stem Cells Technology No.2 Environmental Protection Materials No.4 Zhuan Hua Yi Xue No.4 Sheng Wu Ji Materials No.5 Biotechnology Materials No.6 Zai Sheng Yi Xue No.7 Cowhide Leather Materials No.8 Sheng Ming Ke Xue Yan Jiu No.9 Stem Cells No.10 Xi Bao Zhi Liao No.10 Yi Xue Ke Yan No.20 Materials Technology 科技型中小企业 国家科技型中小企业 高新技术企业 省级专精特新中小企业 省级高新技术企业 省级创新型中小企业
More

Company Overview

  • Nature: Listed Company Size: 500-999 employees Founded: 27年
  • Industry: Pharmaceutical/Biotechnology 、 Raw Materials and Processing 、 Medical Equipment/Devices
  • Full name: Guanhao Biotech Co., Ltd.。

Development Stage

  • Stage: IPO上市, 创业板, 深交所。
  • Ranking: Ranked #1 in Guangzhou Stem Cells Technology Company by popularity Ranked #2 in Guangzhou Environmental Protection Materials Company by popularity Ranked #4 in Guangzhou Zhuan Hua Yi Xue Company by popularity Ranked #4 in Guangzhou Sheng Wu Ji Materials Company by popularity
  • Honors: 科技型中小企业 国家科技型中小企业 According to algorithm
  • Salary: 50.5% of positions earn 8-15K, In 2026 vs last yeargrew by 13%.。Master's salary: ¥19.1K, Doctorate salary: ¥30.0K.
  • R&D: "Medical & Health/Beauty & Healthcare" demand: 18%, "Computer/Network/Technology": 15.7%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 7.9%。
  • Recruiting: In 2026 vs 2025decreased by 59%. Demand for highly educated talent: Master's: 2, Doctorate: 2.
  • Requirement: Education: 本科 leads with 39.3%. Experience: 1-3年 leads with 30.3%.
  • Region: Distributed across 3 regions, 广州: 44.9%, 中山: 11.2%, 北京: 9%, 黄冈: 4.5%.

About the Company

[Summary] Provider of regenerative medicine products, technologies, and services

Guanhao Biotech Co., Ltd. (hereinafter referred to as "Guanhao Biotech"), the predecessor of the company was established in California, USA in 1997, returned to China for entrepreneurship in 1999, and was listed on the ChiNext board of the Shenzhen Stock Exchange in 2011, with stock code 300238.
Guanhao Biotech is a high-tech enterprise based in the regenerative medicine industry, expanding into life and health related fields, integrating global high-end technology resources and achievements, and continuously laying out in biomaterials, cell and stem cells, pharmaceuticals, as well as advanced medical technology and product business fields. After more than ten years of development, the core business has formed a "3+1" pattern, namely materials, cells, pharmaceuticals + technology incubation, with specific businesses covering multiple medical departments such as neurosurgery, ophthalmology, and dermatology.
In the field of regenerative materials, after more than ten years of development, the animal-derived biomaterial technology platform built by the company is a technology platform with international competitiveness. Relying on its leading level in the research and development of new biomaterials with induced regeneration function and their products, Guanhao Biotech undertakes more than twenty national and local scientific and technological projects. The "National Engineering Laboratory for Regenerative Medical Implant Devices" and the "High-tech Industrialization Demonstration Project for Regenerative Biofilm" initiated by the National Development and Reform Commission have successively been settled at Guanhao Biotech. Currently, the company has more than one hundred domestic and foreign patents. The main products on the market include biological dural (spinal) membrane patch, B-type dural patch, thoracic and general surgery repair membrane, sterile biological wound protective film, Aireo breast patch, and Youdeqing acellular corneal implant. Among them, the biological dural (spinal) membrane patch quickly occupied the domestic dural patch market with excellent performance after its launch, completely replacing imported products from Johnson & Johnson and B. Braun, and now ranks among the top in domestic market share; Youdeqing acellular corneal implant adopts a world-first technology, is a product with blindness reversal and vision restoration as the main therapeutic indicators, bringing light to many blind patients. This product and technology have recently been featured in special reports by CCTV's Focus Report and Guangdong TV.
In the field of cell and stem cells, the company is currently involved in autologous chondrocyte tissue transplantation technology and immune cell storage technology, and is continuously laying out in the research and development of immune cell therapy technology. The company cooperates with Peking University and Professor Deng Hongkui's team to establish the Beihao Stem Cell and Regenerative Medicine Research Institute, which will build a common key technology platform for immune cells, gather a group of global advanced talents and technologies, and carry out stem cell and clinical transformation research.
In the pharmaceutical field, the company holds 58.20% equity of Beijing Wenfeng, which owns the intellectual property rights of the Class 1.1 new drug Benvitimod in Greater China. Benvitimod is a non-hormonal small molecule compound isolated from natural microbial metabolites. This drug is the world's first and can be used to treat various autoimmune diseases, such as psoriasis (commonly known as "psoriasis") and eczema, and has been listed by the Ministry of Science and Technology as a major special project for "Significant New Drug Creation" during the "Twelfth Five-Year Plan" period.
In the field of technology incubation, Guanhao Technology Incubation business will operate through a "park + fund" model, integrating global high-end technology research and development resources and achievements, conducting innovative incubation for the Chinese market, focusing on the regenerative medicine industry for early-stage project incubation, forming strong support for materials, cells, and pharmaceutical businesses.
In the future, the company will continue to center around the regenerative medicine biomaterial platform and cell therapy technology platform, integrate resources along the regenerative medicine field, increase the intensity of industrialization transformation, and build Guanhao Biotech into a first-class provider of products, technologies, and services in the regenerative medicine industry.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Guanhao Biotech Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 创业板
  • Deal: 深交所

Guanhao Biotech How Fast Is Hiring Growing? (35 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 64%
  • 2024: Up 147%
  • 2023: Up 10%
  • 2022: Down 40%
Guanhao Biotech Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Guanhao Biotech Campus Recruitment & Advanced Degree Talent Demand
Master's 2 Doctorate 2
Note: How fast is hiring at Guanhao Biotech Co., Ltd. growing? Guanhao Biotech2026: 57 openings (down 59%), 2025: 138 openings (up 64%), 2024: 84 openings (up 147%), 2023: 34 openings (up 10%), 2022: 31 openings (down 40%), 2021: 52 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Guanhao Biotech R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Guanhao Biotech Co., Ltd.? Based on an analysis of Guanhao Biotech's job postings over the past year, "Medical & Health/Beauty & Healthcare" demand: 18%, "Computer/Network/Technology": 15.7%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 7.9%, "Other (R&D and Technical)": 6.7%, "Scientific Research": 2.2%, "Mechanical/Instrumentation": 1.1%. For reference only.

Guanhao Biotech — What Are the Salaries Like? (89 records)

Manage
Guanhao Biotech Salary Overview
salary range: 4.5K - 50K, 50.5% of roles pay ¥8-15K
Note: salary statistics are based on 89 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Guanhao Biotech Co., Ltd.?Guanhao Biotech50.5% of positions earn 8-15K, Undergraduate salary: ¥。Guangzhou salary ranking: #2862,销售类 average salary ¥12.2K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Guanhao Biotech

(More)
Are salaries high at Guanhao Biotech Co., Ltd.? We provide: 商务主管, Business Specialist, Management Trainee, Sales, 销管, Medical Devices, 临床, Product Manager, 区域经理, R&D Engineer, 生物材料, Software Engineer, QC, Information, 妇幼保健, 材料研发, 检测, Production Technician, Hardware, Structural Engineer. Click to view detailed salary analysis by job.

Guanhao Biotech honors, qualifications & industry associations

Job Category

  • 销售类
    39.3% of total 39.3%
  • 经营管理类
    31.5% of total 31.5%
  • 贸易/物流/采购/运输类
    22.5% of total 22.5%
  • 医疗卫生/美容保健类
    18% of total 18%

Education

  • 本科
    39.3% of total 39.3%
  • 大专
    37.1% of total 37.1%
  • 高中
    9% of total 9%
  • 不限
    5.6% of total 5.6%

Experience

  • 1-3年
    30.3% of total 30.3%
  • 3-5年
    29.2% of total 29.2%
  • 不限
    23.6% of total 23.6%
  • 5-10年
    16.9% of total 16.9%
View Detailed Analysis

What does Guanhao Biotech Co., Ltd. require? Who is Guanhao Biotech hiring? Guanhao Biotech recruitment: 销售类占比最多占39.3%,其次是经营管理类占31.5%. What education can get in at Guanhao Biotech? 本科占比最多占39.3%,其次是大专占37.1%. High education required at Guanhao Biotech? 硕士占4.5%,博士占3.4%. Work experience required at Guanhao Biotech? 1-3年占比最多占30.3%,其次是3-5年占29.2%. Where are the job locations at Guanhao Biotech? 广州占比最多占44.9%,其次是中山占11.2%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 26,515.5701万(元)
Legal Representative: 张永明
Date Established:
Credit Code: 91440000707688515X
Registered Address: 广东省广州市黄埔区玉岩路12号

Partners & Suppliers

与广东药科大学共建生物医药产业学院,开展人才培养和科研合作。 Source
供应商 高校研究院合作
冠昊生物获得北京文丰天济1.1类新药苯烯莫德乳膏的国家级经销权,向其采购药品。 Source
供应商 药品供应
冠昊生物为优得清人工角膜产品的全球独家代理商,向其采购人工角膜产品。 Source
供应商 人工角膜供应
与北京大学共建北大冠昊干细胞与再生医学研究院,进行科研合作。 Source
供应商 高校研究院合作
北京信海康为冠昊生物在华北地区的经销商。 Source
合作客户 医疗器械经销商

People who follow Guanhao Biotech also follow

Guanhao Biotech Competitors (Similar Companies)

耐火 控制电缆 屏蔽电缆 同轴电缆
“真空科研仪器设备和干式真空泵”
“A leading enterprise in the domestic intelligent controller industry”
“Research, development, production and sales of printed circuit boards”
模具制造/生产/加工 硫化机 防滑垫 汽车饰件
义齿 义齿加工 齿科 健康体检
ABS 汽车雨刮系统 起动机 蒸发风机
“Plastic packaging supplier”
“One More Degree of Passion”
“Keeping green forever”
“Quality benchmark in the medical dressing industry”
“Member unit of the National Plastics Standardization Technical Committ”
“让生命更有价值”
“团餐行业信息化”

Discover Great Companies, Discover Great Clients

广州公司名录 广州“Huangpu District”公司名录 广州“干细胞”公司名录 广州“再生医学”公司名录 广州“细胞治疗”公司名录 广州“生物材料”公司名录 广州“医疗科技”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates